K.J. Harrison & Partners Inc Decreases Holdings in Kenvue Inc. (NYSE:KVUE)

K.J. Harrison & Partners Inc trimmed its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 84.7% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 66,348 shares of the company's stock after selling 366,160 shares during the period. K.J. Harrison & Partners Inc's holdings in Kenvue were worth $1,428,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Bahl & Gaynor Inc. raised its holdings in shares of Kenvue by 4.8% in the fourth quarter. Bahl & Gaynor Inc. now owns 262,992 shares of the company's stock worth $5,662,000 after buying an additional 12,082 shares during the period. Jackson Hole Capital Partners LLC purchased a new stake in shares of Kenvue in the fourth quarter worth approximately $481,000. State of New Jersey Common Pension Fund D raised its holdings in shares of Kenvue by 10.7% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 966,624 shares of the company's stock worth $20,811,000 after buying an additional 93,478 shares during the period. Syon Capital LLC raised its holdings in shares of Kenvue by 78.4% in the fourth quarter. Syon Capital LLC now owns 29,276 shares of the company's stock worth $630,000 after buying an additional 12,865 shares during the period. Finally, Yacktman Asset Management LP raised its holdings in shares of Kenvue by 43.3% in the fourth quarter. Yacktman Asset Management LP now owns 5,409,457 shares of the company's stock worth $116,466,000 after buying an additional 1,635,395 shares during the period. 97.64% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. Royal Bank of Canada reduced their price objective on Kenvue from $25.00 to $24.00 and set an "outperform" rating on the stock in a report on Friday, February 9th. The Goldman Sachs Group assumed coverage on Kenvue in a report on Friday, March 1st. They set a "neutral" rating and a $20.00 price objective on the stock. William Blair assumed coverage on Kenvue in a report on Wednesday, April 3rd. They set a "market perform" rating on the stock. JPMorgan Chase & Co. reduced their price objective on Kenvue from $25.00 to $24.00 and set an "overweight" rating on the stock in a report on Friday, February 9th. Finally, Sanford C. Bernstein assumed coverage on Kenvue in a report on Thursday, April 11th. They set an "underperform" rating and a $18.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Hold" and an average target price of $24.85.

Kenvue Trading Down 0.8 %

Shares of KVUE stock traded down $0.16 on Friday, hitting $18.86. The company had a trading volume of 15,454,689 shares, compared to its average volume of 13,458,618. The company has a 50-day moving average price of $19.84 and a 200-day moving average price of $20.13. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.78 and a current ratio of 1.12. Kenvue Inc. has a twelve month low of $17.82 and a twelve month high of $27.80.

Kenvue (NYSE:KVUE - Get Free Report) last released its quarterly earnings results on Thursday, February 8th. The company reported $0.31 earnings per share for the quarter, topping analysts' consensus estimates of $0.28 by $0.03. The company had revenue of $3.67 billion during the quarter, compared to analysts' expectations of $3.78 billion. Kenvue had a return on equity of 15.62% and a net margin of 9.87%. The business's revenue was down 2.7% compared to the same quarter last year. Sell-side analysts predict that Kenvue Inc. will post 1.15 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 22nd. Shareholders of record on Wednesday, May 8th will be issued a dividend of $0.20 per share. The ex-dividend date is Tuesday, May 7th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.24%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.